Jacobson, B.F.; Louw, S.; Mer, M.; Haas, S.; Büller, H.R.; Abdul-Carim, A.T.; Adler, D.; Beaton, A.; de Jong, P.R., van der Jagt, D.; Levy, B.; Pearl, J.; Schapkaitz, E.; Wessels, P. .Venous Thromboembolism-prophylactic and therapeutic practice guideline.S Afr Med J.2009.99.6

Sanchez-Antequera, Y.; Cengizeroglu, A.; Kopera A.;, Mykhaylyk, O.; Johnston, J,.; .A novel non-viral and viral technology for ex-vivo gene therapy: Magselectofection.1411 Or 84.ESGCT, DGGT, GSZ, AND ISCT 2009.2009

Trueck, C.; Mykhaylyk, O.; Zimmermann, K.; Wenzel, D.; Becher, U.; Hofmann, A.; Gleich, B.; Fleischmann, B.; Plank, C, Pfeifer, A..Targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles.1386.ESGCT, DGGT, GSZ, AND ISCT 2009.2009

Schillinger, U.; Rutz, M.; Fischer C.; Jahnke A.; Walsch F.; Ferizi, M.; Benda, V.; Schwarz B.; Kempf T.; Hirschberger J.; Köstlin, R.; Brill T., Gänsbacher B.; Plank, C..Adjuvant immunostimulatory therapy by magnetofection prolonged relapse-free survival for fibrosarcoma bearing cats.1384.ESGCT, DGGT, GSZ, and ISCT 2009.2009

Haas, S.New anticoagulants - towards the development of an "ideal" anticoagulant..Vasa.2009.38.1.13-29

Plank, C;Rosenecker, J.Magnetofection: the use of magnetic nanoparticles for nucleic acid delivery..CSH Protoc.2009.2009.6.pdb.prot5230

Mykhaylyk, O;Steingotter, A;Perea, H;Aigner, J;Botnar, R;Plank, C.Nucleic acid delivery to magnetically-labeled cells in a 2D array and at the luminal surface of cell culture tube and their detection by MRI..J Biomed Nanotechnol.2009.5.6.692-706

Obermeier, A;Matl, FD;Friess, W;Stemberger, A.Growth inhibition of Staphylococcus aureus induced by low-frequency electric and electromagnetic fields..Bioelectromagnetics.2009.30.4.270-9

Haas, S;Bauersachs, R.[Prevention of deep vein thrombosis in surgical and non-surgical patients].Hamostaseologie.2009.29.1.91-5

Haas, S.Rivaroxaban -- an oral, direct Factor Xa inhibitor: lessons from a broad clinical study programme..Eur J Haematol.2009.82.5.339-49